Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Web Editors' Choice 2012

By Bloomberg - 2012-12-24T16:25:34Z

Photograph by Emile Wamsteker/Bloomberg

Company Symbol % Change
18 of 25

An Insider Trading Epidemic

A man stands on the fourth floor of an airport parking garage, a letter from his son in his pocket, before jumping to his death. So begins a story on the mainstreaming of insider trading. No longer a felony reserved for Wall Street moguls looking to make millions, insider trading has expanded to the five-figure-salary set, especially in health care, with its long, confidential drug trials. In riveting detail, Bloomberg's David Voreacos tells the tale of the Fans, two promising brothers who, like many people recently accused of insider trading, traded on their knowledge of ongoing clinical drug trials. Eight days after the Bloomberg story appeared, federal prosecutors charged an ex-manager at SAC Capital Advisors LP with insider trading, alleging that he used inside tips about drug trials to net a record $276 million.

Advertisement